| CSX |
Report |
Operating EPS |
BEAT |
pred ~$0.520 vs. cons $0.5135 |
MEDIUM |
| CSX |
Report |
Revenue |
IN-LINE |
pred ~$3.910B vs. cons $3.895B |
MEDIUM |
| CSX |
Report |
Operating income |
IN-LINE |
pred ~$1.450B vs. cons $1.442B |
MEDIUM |
| CSX |
Guide |
FY26 revenue growth |
UNKNOWN |
guide reiterates mid-single digits vs. $15.013B FY consensus |
LOW |
| CSX |
Guide |
FY26 operating margin / OR |
LOWER |
guide ~63.75% OR vs. cons 63.43% |
MEDIUM |
| CSX |
Guide |
FY26 FCF |
UNKNOWN |
guide more than 60% growth vs. cons $3.108B |
LOW |
| CSX |
Guide |
FY26 CapEx |
UNKNOWN |
guide below $2.4B vs. cons UNVERIFIED |
LOW |
| CSX |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.0% |
— |
LOW |
| CSX |
Return |
5-day cumulative residual |
-2.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — elevated setup and no forward validation |
LOW |